Loncar Cancer Immunotherapy ETF (CNCR) は上場企業です 金融 セクターの Asset Management 業界で事業展開.
CNCR を有する IPO日 2015-10-14, に上場 NASDAQ Global Market, 時価総額 $7.04M.
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.
